Autori: Sriuranpong Virote
| Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
| Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
| Projekat | Centus Biotherapeutics |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study (Article) |
| Autori | Thongprasert Sumitra Geater Sarayut L Clement Dana Abdelaziz Amr Reyes-Igama Jasmin Jovanovic Dragana Alexandru Aurelia Schenker Michael Sriuranpong Virote Serwatowski Piotr Suresh Sheethal Cseh Agnieszka Gaafar Rabab |
| Info | LUNG CANCER MANAGEMENT, (2019), vol. 8 br. 3, str. - |
| Projekat | AstraZeneca; Roche; Boehringer Ingelheim; Novartis; Astra Zeneca; Astellas; Bristol Myers Squibb; Eli Lilly; Pfizer; AbbVie; Merck; Merck Serono; Bioven; Pharma Mar; Regeneron; Eisai; Amgern; Mylan |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC (Meeting Abstract) |
| Autori | Thongprasert Sumitra Geater SL Clement D Abdelaziz A Reyes-Igama J Jovanovic D Alexandru A Schenker Michael Sriuranpong Virote Serwatowski P Suresh S Cseh Agnieszka Gaafar Rabab |
| Info | ANNALS OF ONCOLOGY, (2018), vol. 29 br. , Suppl. 9, str. 146-146 |
| Projekat | Boehringer Ingelheim |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
